Tag: Grant

  • WA Child Research Fund 2019/20 Now Open

    The WA Department of Health in conjunction with the Channel 7 Telethon Trust has announced the eighth round of the WA Child Research Fund (formerly the Telethon-Perth Children’s Hospital Research Fund) is now open for applications, with funding to be awarded in 2020.

    Funded research activities may be wide-ranging but must address areas of direct significance to child and adolescent health. Research may include basic, clinical, health service, or population health research.

    If you need assistance navigating the new Consumer and Community Involvement criteria please contact the Consumer & Community Health Research Network.

    Click here for further information, along with the Guidelines and Conditions and the Application Form.

    If you have any questions please contact the Research Development Unit.

     

    Closing date is 1pm, Friday 28 February 2020.

  • Ovarian Cancer Research Grant Opportunity (EPCDR Initiative)

    The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:

    • High quality biomedical, clinical, health services and/or population health research which improves patient care
    • Translation of new discoveries into clinical practice
    • New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
    • Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
    • Many Australians with debilitating conditions

     

    The objectives of the 2019 Ovarian Cancer Research grant opportunity aims to:

    • Facilitate innovative, high quality research which will lead to:
      • Improved diagnosis and treatment of ovarian cancer
      • Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of ovarian cancer
      • Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
      • Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
      • Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
      • Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
      • Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

     

    The total amount available is $20 million. Applications must be submitted electronically via the Research Grants Management System (RGMS).

    Applications close 2pm (AWST), Wednesday 5 February, 2020. More information

  • Discovery Indigenous Funding 2021

    The Discovery Indigenous scheme provides grant funding to support research projects led by an Aboriginal and Torres Strait Islander researcher.

     

    The scheme aims to:

    • Support excellent basic and applied research and research training by Aboriginal and Torres Strait Islander researchers as individuals and as teams
    • Support national and international research collaboration
    • Enhance the scale and focus of research in Australian Government priority areas
    • Support and retain established Aboriginal and Torres Strait Islander researchers in higher education institutions

     

    The intended outcomes of the scheme are:

    • Expanded knowledge base and research capacity in Australia
    • Economic, commercial, environmental, social and/or cultural benefits for Australia

     

    To be eligible the application must:

    • Be submitted through the Research Office of an Eligible Organisation listed in the Grant Guidelines
    • Must nominate at least one Chief Investigator (CI) or a Discovery Aboriginal and Torres Strait Islander Award (DAATSIA) candidate
    • The first named CI must be an Aboriginal and Torres Strait Islander researcher and will be the Project Leader
    • To be eligible to apply as a DAATSIA candidate, the individual nominated must be an Aboriginal and Torres Strait Islander
      • As at the grant opportunity closing date not be nominated for more than one DAATSIA in any given year
    • To be eligible to apply as a CI, DAATSIA candidate or Partner Investigator (PI), the individual nominated must as the grant opportunity closing date:
      • Have met their obligations regarding previously funded projects, including submission to the ARC of satisfactory final reports
    • A CI or DAATSIA candidate must meet at lest one of the following criteria at the grant commencement date:
      • Be an employee for at least 20% full time equivalent (0.2 FTE) at an Eligible Organisation
      • Or be a holder of an honorary academic appointment at an Eligible Organisation

    For further eligibility requirements please read the Grant Guidelines

     

    Application Submission Instructions:

    • Must be submitted as a mature research plan presenting the proposed project ready for implementation and must contain all the information necessary for its assessment without the need for further written or oral explanation, or reference to additional documentation (unless requested by the ARC)
    • Applicants should note the eligibility criteria for access to other funding schemes, as expressed in the Grant Guidelines for those schemes
    • Administering Organisations must submit applications through the Research Management System (RMS) unless otherwise advised by the ARC
    • All applications must meet the format and content requirements, including certification, as set out in the RMS online form and the Instructions to Applicants for Discovery Indigenous for funding commencing in 2021

     

    There is between $30,000 up to $2.5 million available for funding.

     

    Applications close 2pm (AWST), Wednesday 18 March, 2020. Read more information

  • Endometriosis Research Grant Opportunity (EPCDR Initiative)

    The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:

    • High quality biomedical, clinical, health services and/or population health research which improves patient care
    • Translation of new discoveries into clinical practice
    • New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
    • Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
    • Many Australians with debilitating conditions

     

    The objectives of the 2019 Endometriosis Research grant opportunity aims to:

    • Facilitate innovative, high quality research which will lead to:
      • Improved diagnosis and treatment of endometriosis
      • Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of endometriosis
      • Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
      • Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
      • Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
      • Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
      • Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

     

    The total amount available is $9 million. Applications must be submitted electronically via the Research Grants Management System (RGMS). More information

     

    Applications are now open, with minimum data due 22 January, 2020. Applications close 2pm (AWST), Wednesday 5 February, 2020.

     

     

  • WAHTN awarded Federal Budget funds for the Rapid Applied Research Translation program

    Today the Australian Government’s Minister for Health, Hon. Greg Hunt MP, has announced eight national translation research centres, including the Western Australian Health Translation Network (WAHTN), will receive more than $33 million for research into health care practices and interventions. The funding will focus on people with, or at risk of, developing chronic conditions.

    The WAHTN has been awarded $4.14 million in the latest round of the Australian Government’s Medical Research Future Fund (MRFF) as part of the Rapid Applied Research Translation (RART) program. This round of RART grants was targeted to primary care research, with an emphasis on multidisciplinary care and public health interventions which address lifestyle factors which lead to chronic disease. This builds on $1.97 million previously awarded to WAHTN in 2018, totalling $6.1 million provided by the Australian Government over three years.

    Commenting on the successful funding application, Executive Director of WAHTN, Professor Gary Geelhoed, said “The awarding of these funds to WAHTN and to similar bodies around Australia, comprising the Australian Health Research Alliance (AHRA), confirms the ongoing commitment of the National Health and Medical Research Council (NHMRC) and MRFF to the importance of these entities in promoting medical research and its timely application.”

    The grant will provide funding for 12 research projects from WAHTNs Health Service Translational Research Projects (HSTRP) initiative, three Targeted Translational Research (TTR) Fellowships and several National System Level Initiatives, which are projects carried out across the nine AHRA Centres throughout Australia.

    The TTR Fellowships align with WAHTNs aim to support our emerging research talent. Along with building and strengthening the research workforce within WA and enhancing our capacity and capability to undertake high quality translational research. The Fellowships will be targeted to the research areas of:

    • Wound Care
    • Biostatistics

    The HSTRP program attracted 68 applications from the public and private health sector, PathWest and the WA Primary Health Alliance. The large number of quality applications made the process highly competitive. It also provided an encouraging snapshot of the strength and breadth of translational health research occurring in WA hospital and primary health settings. The successful projects, listed in the table below, will be supported by $2.84 million in MRFF funding, with matched funding from the health services.

     

    Read the Australian Government’s media release 

     

    The successful HSTRP recipients are:

    Recipient Project Title Health Service
    Dr Christopher Brennan-Jones PCH Ear Portal: Improving access to specialist ENT and Audiology services in metropolitan Perth Child and Adolescent Health Service
    Dr André Schultz Implementation of solutions to improve follow-up for Aboriginal children hospitalised with lower respiratory tract infections Child and Adolescent Health Service
    Prof Graham Hillis Community based education and exercise training in heart failure: Harnessing an existing resource to bridge a gap East Metropolitan Health Service
    Prof Christobel Saunders Measuring the cost of continuous improvement in care-cancer at Royal Perth Hospital – a ‘proof-of-concept’ East Metropolitan Health Service
    Assoc Prof Paul Cohen Getting the MOST out of follow-up: a randomised controlled trial to compare three-monthly nurse-led telephone follow-up, including monitoring serum CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic-based follow-up, following completion of first-line chemotherapy in patients with epithelial ovarian cancer North Metropolitan Health Service
    Prof Michael Millward Integrating Tumour Mutational Burden (TMB) testing for appropriate selection of immuno-oncology therapy in metastatic melanoma fit for the modern era North Metropolitan Health Service
    Prof Girish Dwivedi High Performance Medicine through Artificial Intelligence in the Emergency Department South Metropolitan Health Service
    Assoc Prof Andrew Maiorana Primary Care Adherence to Heart Failure guidelines IN Diagnosis, Evaluation and Routine management (PATHFINDER) Study South Metropolitan Health Service
    Dr Wei-Sen Lam TeleTrials in WA: A feasibility study to develop and pilot a TeleTrials framework to bring clinical trials closer to home for country patients WA Country Health Service
    Ms Jo Moore A community and health system partnership to prevent hospitalisation and improve outcomes through a Compassionate Communities Model of End of Life Care WA Country Health Service
    Prof Desiree Silva Embedding E-Health (Pregnancy Lifestyle, Activity, Nutrition (PLAN)) into routine clinical practice pathways to provide a healthy start to life Ramsay Health Care
    Mr Richard Varhol Unlocking the potential of health system integration through data linkage: Combining primary and secondary data across the continuum of care to support policy development and clinical management of chronic disease in WA WA Primary Health Alliance
  • Raine Medical Research Foundation Grants – Closing Soon!

    Please note the below funding opportunities all close 1pm (AWST), Thursday 19 September, 2019. Guidelines, Conditions and Applications Forms

     

    Visiting Fellow Awards

    Raine Visiting Professor Awards

    These Awards facilitate the visits of distinguished scholars to Western Australia for the purpose of advancing medical research. Nominations are invited for 2020 and are open to medical researchers from WA Universities or affiliated medical research institutions in Western Australia.

    Charter Hall Visiting Postdoctoral Scholar Awards

    This Award facilitates the visit of a high-achieving postdoctoral research scholar who is within seven years of completing their PhD, for the purpose of advancing medical research. Nominations are invited for 2020 visits and are open to medical researchers from WA Universities or affiliated medical research institutions in Western Australia.

    Read more about the Visiting Fellow Awards

     

    Research Collaboration Awards

    Healy Research Collaboration Awards

    These Awards are for early-career researchers in Western Australia to establish and develop research collaborations, both nationally and internationally, to seek a better understanding of the nature, origin, and cause of human diseases, and their prevention and treatment. A maximum of $30,000 shall be available for each Award.

    BrightSpark Research Collaboration Awards

    These Awards are for early-career researchers in Western Australia, to develop research collaborations that investigate the cause and treatment of childhood disease. A maximum of $30,000 shall be available for each Award.

    Charter Hall Research Collaboration Awards

    These Awards are for early-career researchers in Western Australia, to develop research collaborations that investigate the cause and treatment of childhood disease. A maximum of $30,000 shall be available for each Award.

    Cockell Research Collaboration Awards
    These Awards are for researchers in Western Australia from early-career, mid-career, to senior scientists, to develop research collaborations that investigate the cause and treatment of mental illness. A maximum of $30,000 shall be available for each Award.

    Read more about the Research Collaboration Awards

     

    Publication Prizes

    Raine Research Prize

    This Prize is awarded for the best scientific paper arising from research undertaken by an early-career medical researcher in Western Australia. The successful applicant will receive a travel allowance to the value of $5,000 and a medallion.

     

    Strachan Memorial Prize

    This Prize is awarded to a Western Australian early-career clinical scientist for the most outstanding scientific paper that may translate medical science into better health outcomes. The successful applicant will receive a travel allowance to the value of $5,000 and a medallion.

    Read more about the Publication Prizes

  • New Medical Research Future Fund Investigator Grants Opportunity

    The Medical Research Future Fund (MRFF) Investigator Grants is a new opportunity to ensure the next generation of Australian researchers have the capacity to make and progress medical discoveries. The Investigator Grants also aim to promote opportunities for clinical researchers to work in partnership with professional colleagues and industry.

     

    The objectives of the Grants is to support the research program of outstanding early- to mid-career clinical researchers which contribute to the following MRFF priority research areas:

    1. Australian Brain Cancer Mission
    2. Million Minds Mission
    3. Genomics Health Futures Mission
    4. Ageing, Aged Care and Dementia Mission
    5. Indigenous Health Research Fund
    6. Stem Cell Therapies Mission
    7. Mission for Cardiovascular Health
    8. Traumatic Brain Injury Mission
    9. Preventative and Public Health Research
    10. Primary Health Care Research
    11. Global Health – Tacking Antimicrobial Resistance and Drug Resistant Tuberculosis

     

    In line with the MRFF supporting and funding research translation, all applicants will need to also demonstrate how the grant will influence one or more of the following:

    • Best practice clinical care
    • Commercial health or medical research product / technology development
    • Health policy
    • Health system improvement

     

    The Grant will consolidate salary and research support into a single grant scheme by offering a salary component (if required) and a Research Support Package (RSP).

     

    To support its objective, this Grant opportunity will only support applicants at the Emerging Leadership (EL) category of the National Health and Medical Research Council (NHMRC) Investigator Grant scheme. The EL Category is restricted to researchers who are less than, or equal to, 10 years post-PhD or equivalent and comprises two salary levels (EL1 and EL2) with corresponding RSPs.

     

    Read more about this Grant Opportunity

    Applications close 2pm (AWST), Wednesday 27 November, 2019.

    Read the MRFF Investigator Grants Forecast Opportunity Guidelines

  • $21 million in funding for dementia research

    WAHTN commends the Australian Government for setting aside an additional $21 million for dementia research. This is a significant area of research and the funds will help focus research on risk reduction, prevention and tracking of dementia – which is Australia’s second leading cause of death.

     

    The need for investment in research to develop new treatments and to improve dementia care is evident. The $21 million is in addition to the $185 million Dementia,  Ageing and Aged Care 10 year mission which is funded through the Australian Government’s Medical Research Future Fund (MRFF).

     

    We congratulate the recipients of the 13 funded projects (listed below) who are all part of our Australian Health Research Alliance (AHRA) partner organisations.

     

    Funded Projects from Round 5 – Dementia Risk Reduction and Prevention:

    Chief Investigator Project Title Organisation
    Assoc Prof Lisbeth Evered The PROJECT Trial: PeRiOperaTive Enhancement of Cognitive Trajectory University of Melbourne
    Prof Kaarin Anstey Translating the evidence on dementia risk reduction to generate assessments, advice and training for health professionals, policy makers, patients and public University of New South Wales
    Prof Andrew Pipingas Mediterranean diet and exercise to reduce cognitive decline and dementia risks in independent living older Australians: the MedWalk randomised controlled trial Swinburne University of Technology
    Dr Ashleigh Smith Living your best day – Optimising activity and diet compositions for dementia prevention University of South Australia
    Prof Sharon Naismith REducing Sleep Apnoea for the PrEvention of Dementia (REShAPED): a multi-site feasibility RCT University of Sydney
    Prof Katherine Samaras Preventing cognitive decline with metformin: a randomised controlled trial The Garvan Institute of Medical Research
    Dr Paul Gardiner Taking a whole of day approach to optimising activity to prevent dementia in people with type 2 diabetes The University of Queensland
    Dr Yen Ying Lim BetterBrains: Person-Centred, Multi-Domain, Primary Prevention Strategies to Delay Memory Decline University of Melbourne
    Dr Johnson George Holistic Approach in Primary care for Preventing Memory Impairment aNd Dementia (HAPPI MIND) Monash University
    Assoc Prof Amy Brodtmann Cardiovascular exercise to prevent cognitive decline in high risk patient populations: a post-ischaemic stroke exercise intervention study University of Melbourne
    Assoc Prof Edward Strivens Reducing dementia risk in Aboriginal and Torres Strait Islander Communities James Cook University

     

    Funded Projects from Round 6 – Improving Dementia Data and Methods:

    Chief Investigator Project Title Organisation
    Prof Annette Dobson Improving Australia’s Dementia Statistics The University of Queensland
    Prof Velandai Srikanth Leveraging electronic medical records and routine administrative data towards a population approach for monitoring dementia frequency, risk factors and management Monash University

     

  • Congenital Heart Disease Grant Opportunity

    The Congenital Heart Disease (CHD) grant opportunity forms part of the Accelerated Research Initiative, funded through the Medical Research Future Fund (MRFF).

     

    The CHD grant opportunity supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease.

     

    For this grant opportunity $20 million is available over 5 years from 2019-2020 through to 2023-24.

     

    Other points to note:

    • There’s no minimum grant amount
    • The maximum grant amount is $10 million
    • The grant amount will be up for 100% of eligible project costs
    • Project must be completed by 30 June 2024

     

    The CHD grant application closing date is: 3pm, Thursday 12 September 2019

    Read the key documents and apply here

  • Cancer Council WA funding

    The Cancer Council WA have two funding opportunities now open for applications.

     

    The opportunities are:

    • Cancer Council WA Postdoctoral Fellowship – applications close Friday 19 August 2019
    • Cancer Council WA Student Vacation Scholarships – applications close Tuesday 13 August 2019

     

    The Postdoctoral Fellowship is open to biomedical and health researchers and is worth up to $75,000 each year for 3 years. With funding available from January 1, 2020. This funding will be awarded to an outstanding Early Career Researcher who will contribute to the field of cancer research in Western Australia (WA). Read the guidelines and application forms

     

    The Student Vacation Scholarships aim to encourage promising students to develop and advance their cancer-related research skills during the 2019-2020 summer holiday period. The scholarships are available to students studying disciplines related to cancer control (including biological science, medicine, behavioural science or public health). Up to $3,000 is available for each scholarship. Read the guidelines and application form

     

    For more information contact the Cancer Council WA Education & Research Office